Quantillion Research β June additions
Five names from this month's research universe, ranked by our internal Research Score (1β5).
πDG β Discount Retail β 4.70/5
Dollar General delivered fiscal-Q4 EPS of $1.93 (~20% above forecast) and 4.3% same-store-sales growth on both traffic and basket size, while expanding full-year gross margin 107 basis points, helped by an 80-bp reduction in shrink.
With ~20,500 stores and roughly 75% of the U.S. population within five miles of one, it trades at a forward P/E near 14 and a PEG of ~0.44. The score reflects a mixed revision trend β 3 upward EPS revisions against 14 down over 90 days.
πNBIX β Biotech / Neuroscience β 4.88/5
In Q3 2025, Neurocrine delivered net product sales of $790M, up 28% year-over-year, led by INGREZZA at $687M with record new-patient starts, while CRENESSITY added $98M in just its third quarter on market.
The balance sheet carries $2.1B in cash and no debt, funding sales-force expansion across both franchises β INGREZZA still reaches only ~10% of an ~800,000-patient tardive-dyskinesia population. Ten upward EPS revisions came against five down; the score is held by a richer PEG near 2.9.
πQCOM β Semiconductors / Wireless β 4.46/5
Qualcomm beat fiscal Q2 2026 (EPS $2.65 vs $2.55) and shares gained ~15% over the following week. Diversification is showing: automotive revenue hit $1.3B ( 38% YoY) toward a $6B annual run-rate, IoT reached $1.7B, and the company secured an AI-chip deal with ByteDance plus a custom-silicon engagement with a hyperscaler. It yields ~1.5% with a 23-year dividend streak. The score reflects a real caution β 23 downward EPS revisions over 90 days and memory-supply constraints.
πIBP β Building Products β 4.74/5
Installed Building Products has diversified from 78% to 60% insulation revenue and cut new single-family exposure from 75% to 57% since 2015.
Its Q3 2025 quarter beat with adjusted EPS of $3.18 vs $2.73, and the balance sheet is conservative β net debt to adjusted EBITDA of 1.09x against a 2x target β with ~$213M returned to shareholders over the first nine months of 2025 and 10 upward EPS revisions against none down. The score reflects a full multiple, with a forward P/E near 25.
πTCOM β Online Travel β 4.82/5
Trip grew 2025 net revenue 17% to RMB 62.4B on ~RMB 1.1T of gross bookings, with its international OTA platform up 60% and inbound travel to China more than doubling to ~20M travelers.
It holds a fortress balance sheet β RMB 105.8B in cash β and trades at a P/E near 6 with a PEG of ~0.07. The score carries a clear offset: an antitrust review by China's market regulator opened in early 2026, alongside a soft twelve-month share performance.
β
For research purposes only. This is not an investment idea, not investment advice, not a recommendation, and not an offer or solicitation. Quantillion Research Scores (1β5) are an internal qualitative synthesis of data β not a rating of any security or regulated entity. Past performance is not an indicator of future performance.